ESSA Interest Expense from 2010 to 2024

EPIX Stock  USD 1.83  0.07  3.98%   
ESSA Pharma Interest Expense yearly trend continues to be fairly stable with very little volatility. Interest Expense will likely drop to 5,935 in 2024. Interest Expense is the cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit. View All Fundamentals
 
Interest Expense  
First Reported
2013-09-30
Previous Quarter
0.0
Current Value
0.0
Quarterly Volatility
232.6 K
 
Yuan Drop
 
Covid
Check ESSA Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ESSA Pharma's main balance sheet or income statement drivers, such as Discontinued Operations of 0.0, Interest Expense of 5.9 K or Selling General Administrative of 7.5 M, as well as many indicators such as Price To Sales Ratio of 272.8 K, Dividend Yield of 0.0 or PTB Ratio of 52.01. ESSA financial statements analysis is a perfect complement when working with ESSA Pharma Valuation or Volatility modules.
  
Check out the analysis of ESSA Pharma Correlation against competitors.
For more information on how to buy ESSA Stock please use our How to Invest in ESSA Pharma guide.

Latest ESSA Pharma's Interest Expense Growth Pattern

Below is the plot of the Interest Expense of ESSA Pharma over the last few years. It is the cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit. ESSA Pharma's Interest Expense historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in ESSA Pharma's overall financial position and show how it may be relating to other accounts over time.
Interest Expense10 Years Trend
Very volatile
   Interest Expense   
       Timeline  

ESSA Interest Expense Regression Statistics

Arithmetic Mean271,780
Geometric Mean0.00
Coefficient Of Variation138.37
Mean Deviation332,947
Median22,220
Standard Deviation376,062
Sample Variance141.4B
Range938K
R-Value(0.05)
Mean Square Error151.9B
R-Squared0
Significance0.86
Slope(4,176)
Total Sum of Squares2T

ESSA Interest Expense History

2024 5935.41
2023 6247.8
2022 6942.0
202114 K
202022.2 K
2019618 K
2018603 K

About ESSA Pharma Financial Statements

ESSA Pharma investors use historical fundamental indicators, such as ESSA Pharma's Interest Expense, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in ESSA Pharma. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Interest Expense6.2 K5.9 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for ESSA Stock Analysis

When running ESSA Pharma's price analysis, check to measure ESSA Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ESSA Pharma is operating at the current time. Most of ESSA Pharma's value examination focuses on studying past and present price action to predict the probability of ESSA Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ESSA Pharma's price. Additionally, you may evaluate how the addition of ESSA Pharma to your portfolios can decrease your overall portfolio volatility.